References
1. Suri V AA. Management of endometrial cancer. Vol. 106, Obstetrics and Gynecology. 2005. p. 413–25.
2. Endometrial cancer statistics | World Cancer Research Fund [Internet]. [cited 2020 Jan 13]. Available from: https://www.wcrf.org/dietandcancer/cancer-trends/endometrial-cancer-statistics
3. Abu-Rustum NR. Sentinel lymph node mapping for endometrial cancer: A modern approach to surgical staging. Vol. 12, JNCCN Journal of the National Comprehensive Cancer Network. Harborside Press; 2014. p. 288–97.
4. Matsuo K, Machida H, Frimer M, Marcus JZ, Pejovic T, Roman LD, et al. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer. Gynecol Oncol. 2017 Dec 1;147(3):558–64.
5. Colombo N, Creutzberg C, Amant F, Bosse T, González-Martón A, Ledermann J, et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. Ann Oncol. 2016 Jan 1;27(1):16–41.
6. Rajkumar S, Nath R, Lane G, Mehra G, Begum S, Sayasneh A. Advanced stage (IIIC/IV) endometrial cancer: Role of cytoreduction and determinants of survival. Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:26–31.
7. Buda A, Restaino S, Di Martino G, De Ponti E, Monterossi G, Dinoi G, et al. The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study. Eur J Surg Oncol. 2018 Oct 1;44(10):1562–7.
8. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol. 1991;78(1):63–9.
9. Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. Gynecol Oncol. 2013 Feb;128(2):300–8.
10. Haldorsen IS, Salvesen HB. What Is the Best Preoperative Imaging for Endometrial Cancer? Vol. 18, Current Oncology Reports. Current Medicine Group LLC 1; 2016. p. 1–11.
11. Epstein E, Blomqvist L. Imaging in endometrial cancer. Best Pract Res Clin Obstet Gynaecol. 2014;
12. Zhu M, Jia N, Huang F, Liu X, Zhao Y, Tao X, et al. Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection? BMC Cancer. 2017 Oct 23;17(1).
13. Bendifallah S, Koskas M, Ballester M, Genin AS, Darai E, Rouzier R. The survival impact of systematic lymphadenectomy in endometrial cancer with the use of propensity score matching analysis. Am J Obstet Gynecol. 2012;206(6):500.e1-500.e11.
14. Ghanem AI, Khan NT, Mahan M, Ibrahim A, Buekers T, Elshaikh MA. The impact of lymphadenectomy on survival endpoints in women with early stage uterine endometrioid carcinoma: A matched analysis. Eur J Obstet Gynecol Reprod Biol. 2017 Mar 1;210:225–30.
15. Critical Appraisal Skills Programme. CASP Qualitative Checklist. Casp. 2018;
16. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018 Oct 2;169(7):467.
17. Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Vol. 6, PLoS Medicine. 2009.
18. Todo Y, Watari H, Kang S, Sakuragi N. Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer. J Obstet Gynaecol Res. 2014 Feb;40(2):317–21.
19. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Vol. 105, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2009. p. 103–4.
20. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125–36.
21. Kim HS, Kim HY, Park CY, Lee JM, Lee JK, Cho CH, et al. Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: A multi-center study. Eur J Surg Oncol. 2012 Mar;38(3):230–7.
22. Lucic N, Draganovic D, Sibincic S, Ecim-Zlojutro V, Milicevic S. Myometrium Invasion, Tumour Size and Lymphovascular Invasion as a Prognostic Factor in Dissemination of Pelvic Lymphatics at Endometrial Carcinoma. Med Arch (Sarajevo, Bosnia Herzegovina). 2017 Oct 1;71(5):325–9.
23. Mahdi H, Jernigan A, Nutter B, Michener C, Rose PG. Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion. J Gynecol Oncol. 2015 Jul 1;26(3):208–13.
24. Tomisato S, Yamagami W, Susumu N, Kuwahata M, Takigawa A, Nomura H, et al. Clinicopathological study on para-aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancer. J Obstet Gynaecol Res. 2014 Jun;40(6):1733–9.
25. Polterauer S, Khalil S, Zivanovic O, Abu-Rustum NR, Hofstetter G, Concin N, et al. Prognostic Value of Lymph Node Ratio and Clinicopathologic Parameters in Patients Diagnosed With Stage IIIC Endometrial Cancer. Obstet Gynecol. 2012 Jun;119(6):1210–8.
26. Sorosky JI. Endometrial cancer. Obstet Gynecol. 2012 Aug;120(2 PART 1):383–97.
27. Tewari KS, Filiaci VL, Spirtos NM, Mannel RS, Thigpen JT, Cibull ML, et al. Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: A Gynecologic Oncology Group study. Gynecol Oncol. 2012 Apr;125(1):87–93.
28. Bassarak N, Blankenstein T, Brüning A, Dian D, Bergauer F, Friese K, et al. Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium? BMC Cancer. 2010 May 31;10.
29. Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database of Systematic Reviews. 2017.
30. Coronado PJ, Rychlik A, Martínez-Maestre MA, Baquedano L, Fasero M, García-Arreza A, et al. Role of lymphadenectomy in intermediate-risk endometrial cancer: A matched-pair study. J Gynecol Oncol. 2018;
31. Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006 Nov;103(2):714–8.
32. Carlson JW, Kauderer J, Hutson A, Carter J, Armer JA, Lockwood S, et al. GOG 244, the lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients. Gynecol Oncol. 2018 Jun;149:6–7.
33. Seracchioli R, Solfrini S, Mabrouk M, Facchini C, Di Donato N, Manuzzi L, et al. Controversies in Surgical Staging of Endometrial Cancer. Obstet Gynecol Int. 2010;2010:1–8.
34. Panici PB, Basile S, Maneschi F, Lissoni AA, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial. J Natl Cancer Inst. 2008;
35. Oncoguía SEGO: Cáncer de Endometrio 2010. Guías de práctica clínica en cáncer ginecológico y mamario. Publicaciones SEGO, Octubre 2010.
36. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006 Oct 15;107(8):1823–30.
37. Ouldamer L, Bendifallah S, Body G, Canlorbe G, Touboul C, Graesslin O, et al. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High–Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group. Ann Surg Oncol. 2017 Jun 1;24(6):1660–6.
38. Chan JK, Urban R, Cheung MK, Shin JY, Husain A, Teng NN, et al. Lymphadenectomy in endometrioid uterine cancer staging: How many lymph nodes are enough? A study of 11,443 patients. Cancer. 2007 Jun 15;109(12):2454–60.
39. Multinu F, Ducie JA, Eriksson AGZ, Schlappe BA, Cliby WA, Glaser GE, et al. Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm. Gynecol Oncol. 2019 Nov 1;155(2):177–85.
40. Santaballa A, Matías-Guiu X, Redondo A, Carballo N, Gil M, Gómez C, et al. SEOM clinical guidelines for endometrial cancer (2017). Clin Transl Oncol. 2018 Jan 1;20(1):29–37.
41. Shih KK, Yun E, Gardner GJ, Barakat RR, Chi DS, Leitao MM. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecol Oncol. 2011 Sep;122(3):608–11.
42. Havrilesky LJ, Cragun JM, Calingaert B, Synan I, Secord AA, Soper JT, et al. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol. 2005 Dec;99(3):689–95.
43. Mariani A, Webb MJ, Galli L, Podratz KC. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol. 2000 Mar;76(3):348–56.
44. Numazaki R, Miyagi E, Konnai K, Ikeda M, Yamamoto A, Onose R, et al. Analysis of stage IVB endometrial carcinoma patients with distant metastasis: A review of prognoses in 55 patients. Int J Clin Oncol. 2009 Aug;14(4):344–50.
45. Ueda Y, Enomoto T, Miyatake T, Egawa-Takata T, Ugaki H, Yoshino K, et al. Endometrial carcinoma with extra-abdominal metastasis: Improved prognosis following cytoreductive surgery. Ann Surg Oncol. 2010 Apr;17(4):1111–7.
46. Salehi S, Brandberg Y, Åvall-Lundqvist E, Suzuki C, Johansson H, Legerstam B, et al. Long-term quality of life after comprehensive surgical staging of high-risk endometrial cancer–results from the RASHEC trial. Acta Oncol (Madr). 2018 Dec 2;57(12):1671–6.
47. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging. Gynecol Oncol. 2008 Apr;109(1):11–8.
48. Fotopoulou C, El-Balat A, du Bois A, Sehouli J, Harter P, Muallem MZ, et al. Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer. Arch Gynecol Obstet. 2015 Dec 1;292(6):1321–7.
49. Polan RM, Rossi EC, Barber EL. Extent of lymphadenectomy and postoperative major complications among women with endometrial cancer treated with minimally invasive surgery. Am J Obstet Gynecol. 2019 Mar 1;220(3):263.e1-263.e8.
50. Lim PC, Kang E, Park DH. A comparative detail analysis of the learning curve and surgical outcome for robotic hysterectomy with lymphadenectomy versus laparoscopic hysterectomy with lymphadenectomy in treatment of endometrial cancer: A case-matched controlled study of the first one hundred twenty two patients. Gynecol Oncol. 2011 Mar;120(3):413–8.
51. Johnson L, Bunn WD, Nguyen L, Rice J, Raj M, Cunningham MJ. Clinical comparison of robotic, laparoscopic, and open hysterectomy procedures for endometrial cancer patients. J Robot Surg. 2017 Sep 1;11(3):291–7.
52. Cardenas-Goicoechea J, Soto E, Chuang L, Gretz H, Randall TC. Integration of robotics into two established programs of minimally invasive surgery for endometrial cancer appears to decrease surgical complications. J Gynecol Oncol. 2012;24(1):21–8.
53. Sarlos D, Kots LA. Robotic versus laparoscopic hysterectomy: A review of recent comparative studies. Vol. 23, Current Opinion in Obstetrics and Gynecology. 2011. p. 283–8.
54. Seamon LG, Cohn DE, Henretta MS, Kim KH, Carlson MJ, Phillips GS, et al. Minimally invasive comprehensive surgical staging for endometrial cancer: Robotics or laparoscopy? Gynecol Oncol. 2009 Apr;113(1):36–41.
55. Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, Skinner EN, et al. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy. Am J Obstet Gynecol. 2008;199(4):360.e1-360.e9.
56. Khoury-Collado F, St. Clair C, Abu-Rustum NR. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update. Oncologist. 2016 Apr;21(4):461–6.
57. Selman TJ, Mann CH, Zamora J, Khan KS. A systematic review of tests for lymph node status in primary endometrial cancer. BMC Womens Health. 2008 May 5;8:8.
58. Zahl Eriksson AG, Ducie J, Ali N, McGree ME, Weaver AL, Bogani G, et al. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. Gynecol Oncol. 2016 Mar;140(3):394–9.
59. Tanner EJ, Ojalvo L, Stone RL, Levinson K, Temkin SM, Murdock T, et al. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer. Int J Gynecol Cancer. 2017;27(7):1416–21.
60. Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol. 2017;18(3):384–92.
61. Bedyńska M, Szewczyk G, Klepacka T, Sachadel K, Maciejewski T, Szukiewicz D, et al. Sentinel lymph node mapping using indocyanine green in patients with uterine and cervical neoplasms: restrictions of the method. Arch Gynecol Obstet. 2019 May;299(5):1373–84.